SCOPUS 정보 검색 플랫폼

Integrative Medicine

Volumn 5, Issue 2, 2006, Pages 12-13

Breaking the thought barrier: Musings about placebos and a safer healthcare system

(1) Bland, Jeffrey a,b,c,d

a Institute for Functional Medicine (United States)

b LUCENT TECHNOLOGIES (United States)

c OREGON STATE UNIVERSITY (United States)

d Northwest Academy of Preventive Medicine (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN HEXETIL; CONJUGATED ESTROGEN; FENFLURAMINE; NITRIC OXIDE; PHENTOLAMINE; PLACEBO; ROFECOXIB; SILDENAFIL; VASODILATOR AGENT;

ATTITUDE TO HEALTH; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIET THERAPY; DRUG EFFICACY; DRUG LEGISLATION; DRUG MECHANISM; DRUG SAFETY; ERECTILE DYSFUNCTION; EXERCISE; HEALTH CARE DISTRIBUTION; HEALTH CARE SYSTEM; HEART FAILURE; HUMAN; LIFESTYLE; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL LIABILITY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; NATURAL SELECTION; NOTE; PATIENT COMPLIANCE; PRESCRIPTION; PUBLICATION; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE;

EID: 33748622295 PISSN: 1546993X EISSN: None Source Type: Journal
DOI: None Document Type: Note

Times cited : (1)

References (7)

1
- 26444534291
- "Sildenafil citrate therapy for pulmonary arterial hypertension"
- Galie N, Ghofrani HA, Torbicki A, Barst RJ, et al. "Sildenafil citrate therapy for pulmonary arterial hypertension." N Engl J Medicine. 2005;353:2148-2157.
- (2005) N Engl J Medicine , vol.353 , pp. 2148-2157
- Galie, N.¹ Ghofrani, H.A.² Torbicki, A.³ Barst, R.J.⁴

2
- 29144533834
- "Erectile dysfunction and subsequent cardiovascular disease"
- Thompson IM, Tangen CM, Goodman PJ, Probstgfield JI, et al. "Erectile dysfunction and subsequent cardiovascular disease." J Am Med Assoc. 2005;294:2996-3002.
- (2005) J Am Med Assoc. , vol.294 , pp. 2996-3002
- Thompson, I.M.¹ Tangen, C.M.² Goodman, P.J.³ Probstgfield, J.I.⁴

3
- 28844455699
- "Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomized, controlled clinical trial"
- Granger BB, Swedberg K, Ekman I, Granger CB, et al. "Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomized, controlled clinical trial." Lancet. 2005;366:2005-2011.
- (2005) Lancet , vol.366 , pp. 2005-2011
- Granger, B.B.¹ Swedberg, K.² Ekman, I.³ Granger, C.B.⁴

4
- 28844474002
- "Adherence and outcomes: It's more than taking pills"
- White HD. "Adherence and outcomes: it's more than taking pills." Lancet. 2005 366:1989-1991.
- (2005) Lancet , vol.366 , pp. 1989-1991
- White, H.D.¹

5
- 28944441946
- "Creating a safer health care system"
- Pauker SG, Zane EM, Salem DN. "Creating a safer health care system." JAMA. 2005;294:2906-2907.
- (2005) JAMA , vol.294 , pp. 2906-2907
- Pauker, S.G.¹ Zane, E.M.² Salem, D.N.³

6
- 32944475073
- "How Vioxx is changing US drug regulation"
- Zwillich T. "How Vioxx is changing US drug regulation." Lancet. 2005;366:1763-1764.
- (2005) Lancet , vol.366 , pp. 1763-1764
- Zwillich, T.¹

7
- 28244453652
- "Nature's randomized trials"
- Hingarani A and Humphries S. "Nature's randomized trials." Lancet. 2005;366:1906-1908.
- (2005) Lancet , vol.366 , pp. 1906-1908
- Hingarani, A.¹ Humphries, S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.